Maternal Mirtazapine Selectively Enhances Hippocampal LTP without Reversing Stress-Associated Alterations in Basal Transmission, Short-Term Plasticity, or Open Field Behaviour in Rat Offspring.

IF 2.1 Q3 PHARMACOLOGY & PHARMACY
Drug Research Pub Date : 2025-10-01 Epub Date: 2025-08-29 DOI:10.1055/a-2682-5112
Zdenka Gasparova, Stanislava Bukatova, Michal Dubovicky
{"title":"Maternal Mirtazapine Selectively Enhances Hippocampal LTP without Reversing Stress-Associated Alterations in Basal Transmission, Short-Term Plasticity, or Open Field Behaviour in Rat Offspring.","authors":"Zdenka Gasparova, Stanislava Bukatova, Michal Dubovicky","doi":"10.1055/a-2682-5112","DOIUrl":null,"url":null,"abstract":"<p><p>Maternal stress during pregnancy has profound effects on offspring, disrupting brain development and behaviour. Mirtazapine, an antidepressant commonly prescribed for maternal depression, has an unclear impact on offspring neurophysiology and behaviour. We hypothesized that maternal mirtazapine treatment during pregnancy and lactation would influence locomotor activity, exploratory behaviour, and hippocampal synaptic plasticity in rat offspring, particularly in the context pre-gestational stress.Offspring from control or chronically stressed dams, treated with either vehicle or mirtazapine, were assessed. Behavioural responses were evaluated using the open field test, and the hippocampus was examined electrophysiologically to measure population spike (PS) amplitude of compound action potential, field excitatory postsynaptic potential (fEPSP) slope, short-term plasticity, and long-term potentiation (LTP).Maternal stress significantly reduced exploration of the central zone, indicating increased anxiety-like behaviour, although <i>post hoc</i> comparisons did not reach significance. Mirtazapine treatment did not reverse these behavioural alterations. PS amplitude was unaffected across groups, but fEPSP slope was significantly reduced in stressed offspring, with no recovery observed following mirtazapine treatment. Paired-pulse ratios across inter-pulse intervals (10-100 ms) were consistently decreased in the stressed group, indicating impaired short-term synaptic plasticity, which mirtazapine did not restore. In contrast, LTP showed a significant stress×treatment interaction (<i>p</i>=0.0201), suggesting that mirtazapine selectively enhanced long-term plasticity in stressed offspring.Mirtazapine did not reverse behavioural impairments or basal synaptic transmission deficits induced by maternal stress. It may selectively enhance long-term synaptic plasticity, suggesting its potential to modulate specific neurodevelopmental outcomes following prenatal stress exposure.</p>","PeriodicalId":11451,"journal":{"name":"Drug Research","volume":" ","pages":"308-319"},"PeriodicalIF":2.1000,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Drug Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1055/a-2682-5112","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/8/29 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Maternal stress during pregnancy has profound effects on offspring, disrupting brain development and behaviour. Mirtazapine, an antidepressant commonly prescribed for maternal depression, has an unclear impact on offspring neurophysiology and behaviour. We hypothesized that maternal mirtazapine treatment during pregnancy and lactation would influence locomotor activity, exploratory behaviour, and hippocampal synaptic plasticity in rat offspring, particularly in the context pre-gestational stress.Offspring from control or chronically stressed dams, treated with either vehicle or mirtazapine, were assessed. Behavioural responses were evaluated using the open field test, and the hippocampus was examined electrophysiologically to measure population spike (PS) amplitude of compound action potential, field excitatory postsynaptic potential (fEPSP) slope, short-term plasticity, and long-term potentiation (LTP).Maternal stress significantly reduced exploration of the central zone, indicating increased anxiety-like behaviour, although post hoc comparisons did not reach significance. Mirtazapine treatment did not reverse these behavioural alterations. PS amplitude was unaffected across groups, but fEPSP slope was significantly reduced in stressed offspring, with no recovery observed following mirtazapine treatment. Paired-pulse ratios across inter-pulse intervals (10-100 ms) were consistently decreased in the stressed group, indicating impaired short-term synaptic plasticity, which mirtazapine did not restore. In contrast, LTP showed a significant stress×treatment interaction (p=0.0201), suggesting that mirtazapine selectively enhanced long-term plasticity in stressed offspring.Mirtazapine did not reverse behavioural impairments or basal synaptic transmission deficits induced by maternal stress. It may selectively enhance long-term synaptic plasticity, suggesting its potential to modulate specific neurodevelopmental outcomes following prenatal stress exposure.

母鼠米氮平选择性地增强海马LTP,但不逆转应激相关的基础传递、短期可塑性或开阔场行为改变。
怀孕期间母亲的压力会对后代产生深远的影响,扰乱大脑发育和行为。米氮平,一种常用于治疗母亲抑郁症的抗抑郁药,对后代神经生理和行为的影响尚不清楚。我们假设妊娠和哺乳期母体米氮平治疗会影响大鼠后代的运动活动、探索行为和海马突触可塑性,特别是在妊娠前应激的情况下。对照或长期应激的后代,用对照或米氮平处理。采用开放场试验评估行为反应,并对海马进行电生理检查,以测量复合动作电位的群体峰(PS)幅度、场兴奋性突触后电位(fEPSP)斜率、短期可塑性和长期增强(LTP)。母亲的压力显著减少了对中央区域的探索,表明增加了焦虑样行为,尽管事后比较没有达到显著性。米氮平治疗并没有逆转这些行为改变。各组间PS振幅未受影响,但应激后代的fEPSP斜率显著降低,米氮平治疗后未见恢复。应激组脉冲间间隔(10-100 ms)的成对脉冲比持续下降,表明短期突触可塑性受损,而米氮平并未恢复。相比之下,LTP表现出显著的stress×treatment相互作用(p=0.0201),表明米氮平选择性地增强了应激后代的长期可塑性。米氮平不能逆转由母体应激引起的行为障碍或基础突触传递缺陷。它可能选择性地增强长期突触可塑性,这表明它有可能调节产前应激暴露后特定的神经发育结果。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Drug Research
Drug Research PHARMACOLOGY & PHARMACY-
CiteScore
3.50
自引率
0.00%
发文量
67
期刊介绍: Drug Research (formerly Arzneimittelforschung) is an international peer-reviewed journal with expedited processing times presenting the very latest research results related to novel and established drug molecules and the evaluation of new drug development. A key focus of the publication is translational medicine and the application of biological discoveries in the development of drugs for use in the clinical environment. Articles and experimental data from across the field of drug research address not only the issue of drug discovery, but also the mathematical and statistical methods for evaluating results from industrial investigations and clinical trials. Publishing twelve times a year, Drug Research includes original research articles as well as reviews, commentaries and short communications in the following areas: analytics applied to clinical trials chemistry and biochemistry clinical and experimental pharmacology drug interactions efficacy testing pharmacodynamics pharmacokinetics teratology toxicology.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信